Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Evotec Se (EVTCY)

Evotec Se (EVTCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Evotec Se Manfred Eigen Campus Essener Bogen 7 Hamburg 2M 22419 DEU

www.evotec.com P: 49-4056-0810

Description:

EVOTEC is a leader in the discovery and development of novel small molecule drugs. They have established a powerful platform that is applicable to targets across all therapeutic areas and has specific expertise in the area of Central Nervous System related diseases where it is building a pipeline of drug candidates for partnering. Through research collaborations and proprietary projects They are providing the highest quality research results to its partners in the pharmaceutical and biotechnology industries

Key Statistics

Overview:

Market Capitalization, $K 7,581,874
Shares Outstanding, K 330,221
Annual Sales, $ 572,210 K
Annual Net Income, $ 7,140 K
Last Quarter Sales, $ 166,520 K
Last Quarter Net Income, $ 72,310 K
60-Month Beta 0.98
% of Institutional Shareholders 0.00%
Float, K 330,221
% Float 100.00%

Growth:

1-Year Return 70.04%
3-Year Return 131.16%
5-Year Return 742.57%
5-Year Revenue Growth 303.62%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Latest Earnings Date 11/11/21
Earnings Per Share ttm 0.40
EPS Growth vs. Prev Qtr 15.58%
EPS Growth vs. Prev Year 693.33%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 4-1 on 10/20/21

EVTCY Ratios

Ratio
Price/Earnings ttm 56.02
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 16.02%
Return-on-Assets % 7.81%
Profit Margin % 1.25%
Debt/Equity 0.53
Price/Sales 13.26
Price/Cash Flow 105.48
Price/Book 7.36
Book Value/Share 3.12
Interest Coverage 4.05
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar